Unraveling the spectrum of left bundle branch block in acute myocardial infarction: Insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials

American Heart Journal

Volumn 151, Issue 1, 2006, Pages 10-15

  Al Faleh, Hussam ^a   Fu, Yuling ^a   Wagner, Galen ^b   Goodman, Shaun ^c   Sgarbossa, Elena ^f   Granger, Christopher ^b   Van De Werf, Frans ^d   Wallentin, Lars ^e   W Armstrong, Paul ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UPPSALA UNIVERSITY   (Sweden)

^f 2 51 Medical Sciences Building ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SAFETY; VALIDATION PROCESS;

AGED; BUNDLE-BRANCH BLOCK; CLINICAL TRIALS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK ASSESSMENT;

EID: 29144531959     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.02.043     Document Type: Article

References (13)

1. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Lancet 343 1994 311 322
2. R.C. Klein, Z. Vera, and D.T. Mason Intraventricular conduction defects in acute myocardial infarction: incidence, prognosis, and therapy Am Heart J 108 1984 1007 1013
3. A.S. Go, H.V. Barron, and A.C. Rundle Bundle-branch block and in-hospital mortality in acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators Ann Intern Med 129 1998 690 697
4. E.B. Sgarbossa, S.L. Pinski, and A. Barbagelata Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators N Engl J Med 334 1996 481 487
5. S.F. Li, P.L. Walden, and O. Marcilla Electrocardiographic diagnosis of myocardial infarction in patients with left bundle branch block Ann Emerg Med 36 2000 561 565
6. M.C. Kontos, R.H. McQueen, and R.L. Jesse Can myocardial infarction be rapidly identified in emergency department patients who have left bundle-branch block? Ann Emerg Med 37 2001 431 438
7. J.A. Edhouse, M. Sakr, and J. Angus Suspected myocardial infarction and left bundle branch block: electrocardiographic indicators of acute ischaemia J Accid Emerg Med 16 1999 331 335
8. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction Lancet 358 2001 605 613
9. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Assessment of the Safety and Efficacy of a New Thrombolytic Investigators Lancet 354 1999 716 722
10. G. Gunnarsson, P. Eriksson, and M. Dellborg Bundle branch block and acute myocardial infarction. Treatment and outcome Scand Cardiovasc J 34 2000 575 579
11. K.H. Newby, E. Pisano, and M.W. Krucoff Incidence and clinical relevance of the occurrence of bundle-branch block in patients treated with thrombolytic therapy Circulation 94 1996 2424 2428
12. M.C. Hindman, G.S. Wagner, and M. JaRo The clinical significance of bundle branch block complicating acute myocardial infarction. 1. Clinical characteristics, hospital mortality, and one-year follow-up Circulation 58 1978 679 688
13. E.B. Sgarbossa, S.L. Pinski, and E.J. Topol Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for occluded coronary arteries J Am Coll Cardiol 31 1998 105 110